Skip to main content
. 2020 Nov 17;10(11):e038516. doi: 10.1136/bmjopen-2020-038516

Table 2.

Summary statistics of thresholds of 7-day mortality at 2.5%

Thresholds Sensitivity (%) Specificity (%) PPV (%) LR
Respiratory frequency
 L 2.5% ≤11/min 2.7 (1.6–4.2) 99.6 (99.5–99.6) 11.1 (6.7–17.0) 6.0 (3.7–9.8)
 L 2.5%-U 2.5% 12–18/min
 U 2.5% ≥19/min 52.6 (48.8–56.5) 77.3 (76.8–77.7) 4.6 (4.1–5.1) 2.3 (2.2–2.5)
Systolic blood pressure
 L 2.5% ≤111 mm Hg 32.2 (28.8–35.7) 88.8 (88.5–89.1) 5.5 (4.9–6.3) 2.9 (2.6–3.2)
 L 2.5%-U 2.5% 112–192 mm Hg
 U 2.5% ≥193 mm Hg 4.7 (3.3–6.6) 97.4 (97.2–97.6) 3.6 (2.5–4.9) 1.8 (1.3–2.5)
Heart rate
 L 2.5% ≤53/min 4.5 (3.1–6.3) 97.8 (97.6–97.9) 4.0 (2.7–5.5) 2.0 (1.4–2.9)
 L 2.5%-U 2.5% 54–102/min
 U 2.5% ≥103/min 31.8 (28.4–35.3) 83.1 (82.7–83.5) 3.7 (3.2–4.2) 1.9 (1.7–2.1)
Glasgow Coma Scale
 2.5% ≤14 53.7 (50.3–57.0) 93.2 (93.0–93.5) 16.8 (15.5–18.3) 7.9 (7.4–8.5)
 <2.5% 15
Temperature
 L 2.5% ≤35.9°C 27.2 (23.5–31.2) 88.8 (88.4–89.1) 4.0 (3.4–4.7) 2.4 (2.1–2.8)
 L 2.5%-U 2.5% 36.0°C–39.8°C
 U 2.5% ≥39.9°C 1.1 (0.4–2.4) 99.6 (99.5–99.7) 4.5 (1.7–9.6) 2.7 (1.2–6.2)
Saturation
 2.5% ≤96% 52.8 (48.9–56.6) 73.5 (73.1–74.0) 3.8 (3.4–4.2) 2.0 (1.9–2.2)
 <2.5% 97%–100%
Creatinine
 L 2.5% ≤40 µmol/L 1.7 (0.9–3.0) 99.2 (99.1–99.3) 4.2 (2.2–7.2) 2.0 (1.1–3.6)
 L 2.5%-U 2.5% 41–98 µmol/L
 U 2.5% ≥99 µmol/L 57.0 (53.3–60.7) 79.1 (78.7–79.6) 5.6 (5.1–6.1) 2.7 (2.6–2.9)
PaO2
 L 2.5% ≤9.8 kPa 42.7 (38.2–47.3) 60.8 (59.9–61.7) 4.7 (4.1–5.4) 1.1 (1.0–1.2)
 L 2.5%-U 2.5% 9.9–12.3 kPa
 U 2.5% ≥12.4 kPa 38.7 (34.3–43.3) 72.9 (72.0–73.7) 6.1 (5.3–7.0) 1.4 (1.3–1.6)
Platelets
 L 2.5% ≤164/L 22.4 (19.3–25.8) 88.5 (88.1–88.8) 4.5 (3.8–5.3) 1.9 (1.7–2.3)
 L 2.5%-U 2.5% 165–327/L
 U 2.5% ≥328/L 23.3 (20.1–26.8) 84.9 (84.4–85.3) 3.6 (3.1–4.2) 1.5 (1.3–1.8)
Bilirubin
 <2.5% <13 µmol/L
 2.5% ≥13 µmol/L 41.0 (37.1–44.9) 73.3 (72.8–73.8) 3.3 (2.9–3.7) 1.5 (1.4–1.7)

L, Lower; LR, likelihood ratio; PPV, positive predictive value; U, Upper.